Name | Marinobufagenin |
---|---|
Synonyms |
(3β,5β,15β)-3,5-Dihydroxy-14,15-epoxybufa-20,22-dienolide
5β-Bufa-20,22-dienolide, 14,15β-epoxy-3β,5-dihydroxy- 5beta-Bufa-20,22-dienolide,14,15beta-epoxy-3beta,5-dihydroxy Bufa-20,22-dienolide,14,15-epoxy-3,5-dihydroxy-,(3beta,5beta,15beta) Marinobufagenin Marinobufogenin Marinobufagin Bufa-20,22-dienolide, 14,15-epoxy-3,5-dihydroxy-, (3β,5β,15β)- MARCINOBUFAGIN 5-hydroxyl-resibufogenin |
Description | Marinobufogenin is a strong inhibitor of Na+/K+ ATPase that has been identified in mammalian plasma[1]. |
---|---|
Related Catalog | |
Target |
IC50: Na+/K+ ATPase[1] |
References |
[1]. Daniel N, et al. Bufodienolides in pig plasma and urine. |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 589.0±50.0 °C at 760 mmHg |
Molecular Formula | C24H32O5 |
Molecular Weight | 400.508 |
Flash Point | 203.0±23.6 °C |
Exact Mass | 400.224976 |
PSA | 83.20000 |
LogP | 1.25 |
Vapour Pressure | 0.0±3.7 mmHg at 25°C |
Index of Refraction | 1.621 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | Xi |
---|
Precursor 0 | |
---|---|
DownStream 1 | |